IFIZMA Trademark

Trademark Overview

On Wednesday, June 24, 2015, a trademark application was filed for IFIZMA with the United States Patent and Trademark Office. The USPTO has given the IFIZMA trademark a serial number of 86673090. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2019. This trademark is owned by Pfizer Inc.. The IFIZMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, smoking cessation preparations, tissue repair preparations, and preparations for use in dermatology and oncology; vaccines for human use
ifizma

General Information

Serial Number86673090
Word MarkIFIZMA
Filing DateWednesday, June 24, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, smoking cessation preparations, tissue repair preparations, and preparations for use in dermatology and oncology; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 1, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 11, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 11, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2018EXTENSION 5 GRANTED
Monday, July 16, 2018EXTENSION 5 FILED
Friday, July 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 16, 2018TEAS EXTENSION RECEIVED
Tuesday, January 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 26, 2018EXTENSION 4 GRANTED
Friday, January 26, 2018EXTENSION 4 FILED
Friday, January 26, 2018TEAS EXTENSION RECEIVED
Wednesday, July 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 10, 2017EXTENSION 3 GRANTED
Monday, July 10, 2017EXTENSION 3 FILED
Monday, July 10, 2017TEAS EXTENSION RECEIVED
Wednesday, January 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2017EXTENSION 2 GRANTED
Monday, January 23, 2017EXTENSION 2 FILED
Monday, January 23, 2017TEAS EXTENSION RECEIVED
Saturday, July 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 21, 2016EXTENSION 1 GRANTED
Thursday, July 21, 2016EXTENSION 1 FILED
Thursday, July 21, 2016TEAS EXTENSION RECEIVED
Tuesday, February 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 8, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 29, 2015ASSIGNED TO LIE
Wednesday, September 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 23, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, September 23, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 23, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, September 23, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 23, 2015ASSIGNED TO EXAMINER
Wednesday, July 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 27, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

ifizma preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases